ARCS Forward
Reducing the Impact of Cancer
Tuesday, June 10, at 3:00 PM ET/2:00 PM CT/1:00 PM MT/12:00 PM PT/9:00 AM HT
ARCS Forward events are personal and intimate conversations between members, current scholars, and other outstanding scientists in all STEM fields. These events are held virtually over Zoom.
How can we reduce the impact of cancer in humans? This question led ARCS Scholar Alum Eric DeJesus, PhD, to his research. DeJesus is the Founder and CEO of Annate Bitherapeutics, a biotech company advancing a novel bispecific antibody platform. Join us for a look into what makes his research an outstanding testimony to the importance of STEM.
Eric DeJesus, PhD is a scientist, entrepreneur, and Founder and CEO of Annate Bitherapeutics. His work centers on harnessing a unique component of the innate immune system to selectively kill cancer cells, with lead programs targeting multiple myeloma and pancreatic cancer.
Beyond the science, Dr. DeJesus is deeply committed to developing transformative therapies, not just for cancer, but for human diseases more broadly. His team has built strong preclinical proof-of-concept data, secured intellectual property, and is driving the path toward clinical development.
|
Webinar Event
|
